I Scharrer Selected Research

I Scharrer Research Topics

Disease

12	Hemophilia A (Haemophilia) 01/2014 - 01/2000
10	Hemorrhage 01/2014 - 01/2000
4	Thrombotic Thrombocytopenic Purpura 01/2014 - 08/2002
4	Thrombosis (Thrombus) 01/2007 - 03/2004
4	Thrombophilia 09/2004 - 12/2001
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2007 - 11/2004
3	Venous Thromboembolism 12/2001 - 01/2000
2	Spontaneous Abortion (Miscarriage) 01/2014 - 01/2000
2	Autoimmune Diseases (Autoimmune Disease) 01/2012 - 05/2010
2	Neoplasms (Cancer) 05/2010 - 01/2007
1	acquired Thrombotic thrombocytopenic purpura 05/2013
1	Hypertension (High Blood Pressure) 07/2012
1	Thyroiditis 01/2012
1	Celiac Disease (Celiac Sprue) 01/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2012
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2012
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 12/2008
1	Type 3 von Willebrand Disease 06/2007
1	von Willebrand Diseases (von Willebrand's Disease) 06/2007
1	Pain (Aches) 02/2007
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2007
1	Protein S Deficiency (Deficiency, Protein S) 03/2005
1	Menorrhagia 02/2004
1	Coronary Disease (Coronary Heart Disease) 08/2002
1	Vascular Diseases (Vascular Disease) 08/2002
1	Activated Protein C Resistance (APC Resistance) 11/2000
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2000
1	Chest Pain (Chest Pains) 06/2000
1	Stillbirth 01/2000

Drug/Important Bio-Agent (IBA)

12	Factor VIII (Coagulation Factor VIII)IBA 06/2012 - 01/2000
6	thiamine triphosphorate (TTP)IBA 01/2014 - 08/2002
5	AnticoagulantsIBA 07/2012 - 12/2001
5	Protein CIBA 12/2008 - 11/2000
5	AntibodiesIBA 06/2007 - 03/2001
4	factor V LeidenIBA 03/2005 - 01/2000
3	AutoantibodiesIBA 03/2008 - 01/2000
3	AntithrombinsIBA 03/2005 - 11/2000
3	Sucrose (Saccharose)IBA 03/2002 - 06/2000
3	human F8 protein FDA Link 03/2002 - 06/2000
2	sugar formulated recombinant FVIIIIBA 01/2014 - 06/2000
2	von Willebrand FactorIBA 09/2010 - 06/2007
2	Protein SIBA 09/2004 - 11/2000
1	AntigensIBA 01/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2012
1	Factor XIII (Coagulation Factor XIII)IBA 06/2012
1	Adenosine Diphosphate (ADP)IBA 06/2012
1	Epinephrine (Adrenaline)FDA LinkGeneric 06/2012
1	A-factor (Streptomyces)IBA 06/2012
1	Inosine Triphosphate (ITP)IBA 01/2012
1	Pharmaceutical PreparationsIBA 05/2010
1	Antiphospholipid AntibodiesIBA 01/2007
1	Immunoglobulin M (IgM)IBA 01/2007
1	Chromogenic CompoundsIBA 09/2006
1	Blood Coagulation Factors (Coagulation Factor)IBA 06/2005
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2004
1	vinyltriethoxysilane (VTES)IBA 09/2004
1	Oral ContraceptivesIBA 03/2004
1	ADAMTS13 ProteinIBA 08/2002
1	activated protein C receptorIBA 12/2001
1	Endothelial Protein C ReceptorIBA 12/2001
1	Lipoprotein(a)IBA 11/2000
1	Prothrombin (Factor II)IBA 11/2000
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 11/2000
1	Analgesics (Analgesic Drugs)IBA 06/2000
1	Hemostatics (Antihemorrhagics)IBA 06/2000
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2000
1	Heparin (Liquaemin)FDA LinkGeneric 01/2000
1	prothrombin complex concentrates (PPSB)IBA 01/2000
1	recombinant FVIIa (rFVIIa)FDA Link 01/2000

Therapy/Procedure

4	Therapeutics 07/2012 - 06/2000
2	Operative Surgical Procedures 03/2002 - 11/2000
1	Tonsillectomy 06/2012
1	Hip Replacement Arthroplasty (Total Hip Replacement) 02/2007
1	Cesarean Section (Caesarean Section) 02/2004
1	Aftercare (After-Treatment) 06/2000